Fatal pulmonary veno-occlusive disease possibly related to gemcitabine

被引：18

作者：

Vansteenkiste, JF

Bomans, P

Verbeken, EK

Nackaerts, KL

Demedts, MG

机构：

[1] Univ Hosp Gasthuisberg, Dept Pulmonol, Resp Oncol Unit, B-3000 Louvain, Belgium

[2] Univ Hosp Gasthuisberg, Dept Pathol, B-3000 Louvain, Belgium

来源：

LUNG CANCER | 2001年 / 31卷 / 01期

关键词：

veno-occlusive disease; gemcitabine; carcinoma; non-small cell lung; pulmonary toxicity; case report;

D O I：

10.1016/S0169-5002(00)00159-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：83 / 85

页数：3

共 9 条

[1] Veno-occlusive disease of the liver induced by gemcitabine [J].

Dobbie, M ;

Hofer, S ;

Oberholzer, M ;

Herrmann, R .

ANNALS OF ONCOLOGY, 1998, 9 (06) :681-681

[2] PULMONARY VENO-OCCLUSIVE DISEASE AFTER CHEMOTHERAPY [J].

KNIGHT, BK ;

ROSE, AG .

THORAX, 1985, 40 (11) :874-875

[3] PULMONARY VENOOCCLUSIVE DISEASE FOLLOWING THERAPY FOR MALIGNANT NEOPLASMS [J].

LOMBARD, CM ;

CHURG, A ;

WINOKUR, S .

CHEST, 1987, 92 (05) :871-876

[4] Phase II study of docetaxel alternating with cisplatin in chemotherapy-naive patients with advanced non-small cell lung cancer [J].

Mattson, K ;

Vansteenkiste, J ;

Stupp, R ;

Bargetzi, M ;

Saarinen, A ;

Jekunen, A ;

Fillet, G ;

Teixeira, M ;

Gatzemeier, U ;

Olivares, R ;

Soussan-Lazard, K ;

Bérille, J .

ANTI-CANCER DRUGS, 2000, 11 (01) :7-13

[5] Hemolytic-uremic syndrome caused by Gemcitabine [J].

Nackaerts, K ;

Daenen, M ;

Vansteenkiste, J ;

Vandevelde, A ;

Van Bleyenbergh, P ;

Demedts, M .

ANNALS OF ONCOLOGY, 1998, 9 (12) :1355-1355

[6]

Pavlakis N, 1997, CANCER, V80, P286, DOI 10.1002/(SICI)1097-0142(19970715)80:2<286::AID-CNCR17>3.0.CO

[7]

2-Q

[8]

Salzman D, 1996, BONE MARROW TRANSPL, V18, P755

[9] SINGLE LUNG TRANSPLANTATION - REPLACEMENT THERAPY FOR END-STAGE LUNG-DISEASE [J].

WONG, J ;

LOYD, JE ;

MERRILL, WH ;

FRIST, WH .

SOUTHERN MEDICAL JOURNAL, 1992, 85 (09) :887-893

← 1 →